CMPX EBITDA Margin

Compass Therapeutics · EBITDA Margin

CMPX logo

CMPX EBITDA Margin

Latest reported-6302.24%
CMPX TTM EBITDA Margin (-5338.71% → -6302.24%)
High-resolution chart · PNG

CMPX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Compass Therapeutics EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-6,302.2353%
-5,602.8235%
-5,399.6471%
-5,338.7059%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.